RESUMO
Objective To investigate the clinical condition of incompatibility of common intravenous drug use,investigate variation of drug compatibility and promote rational drug use,reduce nurse-patient disputes and adverse drug reactions occurrence,ensure patient medication safety.Methods To search articles about drug incompatibility by retrieving the Articles Database such as Chinese Journal of Nursing,Chinese Journal of Modern Nursing,Chinese Journal of Practical Nursingfrom 2000 to 2013.The reported clinical drug incompatibility in the literature,involving the number of periodicals dealt with incompatibility,the type of drug compatibility,change of compatibility type,and other circumstances affecting patients were analyzed.Results In a total of 925 issued periodicals,688 articles reported incompatibility,which involved 700 types of drugs,compatibility of drug B involving 824 kinds.The common reported drugs were sodium fusidate,ambroxol injection,pantoprazole sodium omeprazole sodium,vinpocetine.The major compatibility changes were color reaction,turbidity,there-floe or precipitate,bubbles,etc.The incompatibility did not affect the patients generally.Conclusions The incompatibility of many drugs showed certain regular pattern.We should pay attention to the rational confect and clinical use.Nurses should master related knowledge and compatibility variation of the drugs,take effective measures to avoid the occurrence of changes in physical and chemical properties,and effectively promote clinical safety.
RESUMO
AIM: To study the effects of different dose proportioning the danggui-shaoyao powder (DS) on learning and memory and the content of NO in brain in mice. METHODS: The ability of learning and memory was measured by the step-through task and the water maze task. The content of NO in brain was determined referring to the reagent manual. RESULTS: All different dose proportion of DS promoted the memory of normal mice. And only DS 1 (1 5.4) and DS 3 (1 1.34) obviously improved the scopolamine-induced mice passive avoidance handicap, prolonged the latency, and decreased number of errors. DS 3(1 1.34) obviously improved reserpine-induced mice spatial orientation handicap and prolonged the latency; others had no remarkable effect on spatial orientation handicap of mice. And all different dose proportions of DS could reduce the content of NO in the brain of passive avoidance disruption mice induced by scopolamine. CONCLUSION: DS 3 (1 1.34) improves passive avoidance handicap and spatial orientation handicap of mice, and reduced the content of NO in the brain of passive avoidance handicap mice induced by scopolamine. The effect of DS 3(1 1.34) is the best on benefiting memory.